Sfoglia per Autore
Cardiac kinematic parameters computed from video of in situ beating heart
2017-01-01 Fassina, Lorenzo; Rozzi, Giacomo; Rossi, Stefano; Scacchi, Simone; Galetti, Maricla; Lo Muzio, Francesco Paolo; Del Bianco, Fabrizio; Colli Franzone, Piero; Petrilli, Giuseppe; Faggian, Giuseppe; Miragoli, Michele
Titanium dioxide aggregating nanoparticles induce autophagy and under-expression of microRNA 21 and 30a in A549 cell line: A comparative study with cobalt(II, III) oxide nanoparticles
2017-01-01 Alinovi, Rossella; Goldoni, Matteo; Pinelli, Silvana; Ravanetti, Francesca; Galetti, Maricla; Pelosi, Giorgio; De Palma, Giuseppe; Apostoli, Pietro; Cacchioli, Antonio; Mutti, Antonio; Mozzoni, Paola
New MDR1 inhibitors for overcoming multidrug resistance
2018-01-01 Bernini, Franco; Adorni, Maria Pia; Petronini, Pier Giorgio; Alfieri, Roberta; Galetti, Maricla; Favari, Elda; Incerti, Matteo
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab
2019-01-01 Bersanelli, M.; Gnetti, L.; Vaglio, A.; Sverzellati, N.; Campanini, N.; Incerti, M.; Galetti, M.; Varotti, E.; Corrado, M.; Parziale, R.; Bottarelli, L.; Azzoni, C.; Silini, E. M.; Leonardi, F.; Buti, S.
CDK4/6 inhibitors overcome resistance to osimertinib in NSCLC cell lines independently from resistance mechanisms
2019-01-01 Cretella, D; La Monica, S; Minari, R; Cavazzoni, A; Galetti, M; Petronini, P. G.; Tiseo, M; Alfieri, R.
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines.
2019-01-01 Fumarola, C; Bozza, N; Castelli, R; Ferlenghi, F; Marseglia, Giuseppe; Lodola, A; Bonelli, M; La Monica, S; Cretella, D; Alfieri, R; Minari, R; Galetti, M; Tiseo, M; Ardizzoni, A; Mor, M; Petronini, Pg.
Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats
2019-01-01 Rossi, Stefano; Savi, Monia; Mazzola, Marta; Pinelli, Silvana; Alinovi, Rossella; Gennaccaro, Laura; Pagliaro, Alessandra; Meraviglia, Viviana; Galetti, Maricla; Lozano-Garcia, Omar; Rossini, Alessandra; Frati, Caterina; Falco, Angela; Quaini, Federico; Bocchi, Leonardo; Stilli, Donatella; Lucas, Stéphane; Goldoni, Matteo; Macchi, Emilio; Mutti, Antonio; Miragoli, Michele
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC
2019-01-01 La Monica, S.; Minari, R.; Cretella, D.; Flammini, L.; Fumarola, C.; Bonelli, M.; Cavazzoni, A.; Digiacomo, G.; Galetti, M.; Madeddu, D.; Falco, A.; Lagrasta, C. A.; Squadrilli, A.; Barocelli, E.; Romanel, A.; Quaini, F.; Petronini, P. G.; Tiseo, M.; Alfieri, R.
Chapter 9 - Innovation in nanomedicine and engineered nanomaterials for therapeutic purposes
2019-01-01 Galetti, M.; Rossi, S.; Caffarra, C.; Gerboles, A. G.; Miragoli, M.
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion
2019-01-01 La Monica, S.; Minari, R.; Cretella, D.; Bonelli, M.; Fumarola, C.; Cavazzoni, A.; Galetti, M.; Digiacomo, G.; Riccardi, F.; Petronini, P. G.; Tiseo, M.; Alfieri, R.
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells
2019-01-01 Cretella, D.; Fumarola, C.; Bonelli, M.; Alfieri, R.; La Monica, S.; Digiacomo, G.; Cavazzoni, A.; Galetti, M.; Generali, D.; Petronini, P. G.
Highly-defined bioprinting of long-term vascularized scaffolds with Bio-Trap: Complex geometry functionalization and process parameters with computer aided tissue engineering
2020-01-01 Foresti, R.; Rossi, S.; Pinelli, S.; Alinovi, R.; Barozzi, M.; Sciancalepore, C.; Galetti, M.; Caffarra, C.; Lagonegro, P.; Scavia, G.; Mattarozzi, M.; Careri, M.; Macaluso, C.; Miragoli, M.; Selleri, S.
Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer
2020-01-01 Cavazzoni, A.; Digiacomo, G.; Alfieri, R.; La Monica, S.; Fumarola, C.; Galetti, M.; Bonelli, M.; Cretella, D.; Barili, V.; Zecca, A.; Giovannetti, E.; Fiorentino, M.; Tiseo, M.; Petronini, P. G.; Ardizzoni, A.
Dual inhibition of CDK4/6 and PI3K/AKT/mTOR signaling impairs energy metabolism in MPM cancer cells
2020-01-01 Bonelli, M.; Terenziani, R.; Zoppi, S.; Fumarola, C.; La Monica, S.; Cretella, D.; Alfieri, R.; Cavazzoni, A.; Digiacomo, G.; Galetti, M.; Petronini, P. G.
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines
2020-01-01 Digiacomo, G.; Fumarola, C.; La Monica, S.; Bonelli, M. A.; Cretella, D.; Alfieri, R.; Cavazzoni, A.; Galetti, M.; Bertolini, P.; Missale, G.; Petronini, P. G.
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib
2021-01-01 LA Monica, S.; Fumarola, C.; Cretella, D.; Bonelli, M.; Minari, R.; Cavazzoni, A.; Digiacomo, G.; Galetti, M.; Volta, F.; Mancini, M.; Petronini, P. G.; Tiseo, M.; Alfieri, R.
CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells
2022-01-01 Terenziani, Rita; Galetti, Maricla; La Monica, Silvia; Fumarola, Claudia; Zoppi, Silvia; Alfieri, Roberta; Digiacomo, Graziana; Cavazzoni, Andrea; Cavallo, Delia; Corradi, Massimo; Tiseo, Marcello; Petronini, Pier Giorgio; Bonelli, Mara
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
2022-01-01 Digiacomo, Graziana; Fumarola, Claudia; La Monica, Silvia; Bonelli, Mara; Cavazzoni, Andrea; Galetti, Maricla; Terenziani, Rita; Eltayeb, Kamal; Volta, Francesco; Zoppi, Silvia; Bertolini, Patrizia; Missale, Gabriele; Alfieri, Roberta; Petronini, Pier Giorgio
Interaction between occupational radon exposure and tobacco smoke: a systematic review
2022-01-01 Folesani, Giuseppina; Galetti, Maricla; Ranzieri, Silvia; Petronini, Pier Giorgio; La Monica, Silvia; Corradi, Massimo; Cavallo, Delia
CDK4/6 INHIBITORS AS A NEW THERAPEUTIC APPROACH IN MESOTHELIOMA MODELS
2023-01-01 La Monica, S.; Galetti, M.; Alfieri, R.; Cavazzoni, A.; Fumarola, C.; De Forni, D.; Lori, F.; Petronini, P. G.; Bonelli, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cardiac kinematic parameters computed from video of in situ beating heart | 1-gen-2017 | Fassina, Lorenzo; Rozzi, Giacomo; Rossi, Stefano; Scacchi, Simone; Galetti, Maricla; Lo Muzio, Francesco Paolo; Del Bianco, Fabrizio; Colli Franzone, Piero; Petrilli, Giuseppe; Faggian, Giuseppe; Miragoli, Michele | |
| Titanium dioxide aggregating nanoparticles induce autophagy and under-expression of microRNA 21 and 30a in A549 cell line: A comparative study with cobalt(II, III) oxide nanoparticles | 1-gen-2017 | Alinovi, Rossella; Goldoni, Matteo; Pinelli, Silvana; Ravanetti, Francesca; Galetti, Maricla; Pelosi, Giorgio; De Palma, Giuseppe; Apostoli, Pietro; Cacchioli, Antonio; Mutti, Antonio; Mozzoni, Paola | |
| New MDR1 inhibitors for overcoming multidrug resistance | 1-gen-2018 | Bernini, Franco; Adorni, Maria Pia; Petronini, Pier Giorgio; Alfieri, Roberta; Galetti, Maricla; Favari, Elda; Incerti, Matteo | |
| Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab | 1-gen-2019 | Bersanelli, M.; Gnetti, L.; Vaglio, A.; Sverzellati, N.; Campanini, N.; Incerti, M.; Galetti, M.; Varotti, E.; Corrado, M.; Parziale, R.; Bottarelli, L.; Azzoni, C.; Silini, E. M.; Leonardi, F.; Buti, S. | |
| CDK4/6 inhibitors overcome resistance to osimertinib in NSCLC cell lines independently from resistance mechanisms | 1-gen-2019 | Cretella, D; La Monica, S; Minari, R; Cavazzoni, A; Galetti, M; Petronini, P. G.; Tiseo, M; Alfieri, R. | |
| Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. | 1-gen-2019 | Fumarola, C; Bozza, N; Castelli, R; Ferlenghi, F; Marseglia, Giuseppe; Lodola, A; Bonelli, M; La Monica, S; Cretella, D; Alfieri, R; Minari, R; Galetti, M; Tiseo, M; Ardizzoni, A; Mor, M; Petronini, Pg. | |
| Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats | 1-gen-2019 | Rossi, Stefano; Savi, Monia; Mazzola, Marta; Pinelli, Silvana; Alinovi, Rossella; Gennaccaro, Laura; Pagliaro, Alessandra; Meraviglia, Viviana; Galetti, Maricla; Lozano-Garcia, Omar; Rossini, Alessandra; Frati, Caterina; Falco, Angela; Quaini, Federico; Bocchi, Leonardo; Stilli, Donatella; Lucas, Stéphane; Goldoni, Matteo; Macchi, Emilio; Mutti, Antonio; Miragoli, Michele | |
| Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC | 1-gen-2019 | La Monica, S.; Minari, R.; Cretella, D.; Flammini, L.; Fumarola, C.; Bonelli, M.; Cavazzoni, A.; Digiacomo, G.; Galetti, M.; Madeddu, D.; Falco, A.; Lagrasta, C. A.; Squadrilli, A.; Barocelli, E.; Romanel, A.; Quaini, F.; Petronini, P. G.; Tiseo, M.; Alfieri, R. | |
| Chapter 9 - Innovation in nanomedicine and engineered nanomaterials for therapeutic purposes | 1-gen-2019 | Galetti, M.; Rossi, S.; Caffarra, C.; Gerboles, A. G.; Miragoli, M. | |
| Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion | 1-gen-2019 | La Monica, S.; Minari, R.; Cretella, D.; Bonelli, M.; Fumarola, C.; Cavazzoni, A.; Galetti, M.; Digiacomo, G.; Riccardi, F.; Petronini, P. G.; Tiseo, M.; Alfieri, R. | |
| Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells | 1-gen-2019 | Cretella, D.; Fumarola, C.; Bonelli, M.; Alfieri, R.; La Monica, S.; Digiacomo, G.; Cavazzoni, A.; Galetti, M.; Generali, D.; Petronini, P. G. | |
| Highly-defined bioprinting of long-term vascularized scaffolds with Bio-Trap: Complex geometry functionalization and process parameters with computer aided tissue engineering | 1-gen-2020 | Foresti, R.; Rossi, S.; Pinelli, S.; Alinovi, R.; Barozzi, M.; Sciancalepore, C.; Galetti, M.; Caffarra, C.; Lagonegro, P.; Scavia, G.; Mattarozzi, M.; Careri, M.; Macaluso, C.; Miragoli, M.; Selleri, S. | |
| Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer | 1-gen-2020 | Cavazzoni, A.; Digiacomo, G.; Alfieri, R.; La Monica, S.; Fumarola, C.; Galetti, M.; Bonelli, M.; Cretella, D.; Barili, V.; Zecca, A.; Giovannetti, E.; Fiorentino, M.; Tiseo, M.; Petronini, P. G.; Ardizzoni, A. | |
| Dual inhibition of CDK4/6 and PI3K/AKT/mTOR signaling impairs energy metabolism in MPM cancer cells | 1-gen-2020 | Bonelli, M.; Terenziani, R.; Zoppi, S.; Fumarola, C.; La Monica, S.; Cretella, D.; Alfieri, R.; Cavazzoni, A.; Digiacomo, G.; Galetti, M.; Petronini, P. G. | |
| Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines | 1-gen-2020 | Digiacomo, G.; Fumarola, C.; La Monica, S.; Bonelli, M. A.; Cretella, D.; Alfieri, R.; Cavazzoni, A.; Galetti, M.; Bertolini, P.; Missale, G.; Petronini, P. G. | |
| Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib | 1-gen-2021 | LA Monica, S.; Fumarola, C.; Cretella, D.; Bonelli, M.; Minari, R.; Cavazzoni, A.; Digiacomo, G.; Galetti, M.; Volta, F.; Mancini, M.; Petronini, P. G.; Tiseo, M.; Alfieri, R. | |
| CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells | 1-gen-2022 | Terenziani, Rita; Galetti, Maricla; La Monica, Silvia; Fumarola, Claudia; Zoppi, Silvia; Alfieri, Roberta; Digiacomo, Graziana; Cavazzoni, Andrea; Cavallo, Delia; Corradi, Massimo; Tiseo, Marcello; Petronini, Pier Giorgio; Bonelli, Mara | |
| CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells | 1-gen-2022 | Digiacomo, Graziana; Fumarola, Claudia; La Monica, Silvia; Bonelli, Mara; Cavazzoni, Andrea; Galetti, Maricla; Terenziani, Rita; Eltayeb, Kamal; Volta, Francesco; Zoppi, Silvia; Bertolini, Patrizia; Missale, Gabriele; Alfieri, Roberta; Petronini, Pier Giorgio | |
| Interaction between occupational radon exposure and tobacco smoke: a systematic review | 1-gen-2022 | Folesani, Giuseppina; Galetti, Maricla; Ranzieri, Silvia; Petronini, Pier Giorgio; La Monica, Silvia; Corradi, Massimo; Cavallo, Delia | |
| CDK4/6 INHIBITORS AS A NEW THERAPEUTIC APPROACH IN MESOTHELIOMA MODELS | 1-gen-2023 | La Monica, S.; Galetti, M.; Alfieri, R.; Cavazzoni, A.; Fumarola, C.; De Forni, D.; Lori, F.; Petronini, P. G.; Bonelli, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile